FDA grants orphan drug designation to VS-01
Versantis secures a CHF 4.4 M Series A financing.
V Forster about entrepreneurial motivations in Tages Anzeiger
Versantis selected as one of the finest Swiss Startups. Watch the video!
Versantis wins MassChallenge Switzerland!!
Versantis listed in Top10 best Swiss biotech startups and Top50 overall!
HOMEABOUT USDISEASE AREASPRODUCTSNEWSCAREERS
Versantis AGc/o ETH ZurichOtto-Stern-Weg 7, HPL D16.28093 Zurich
Copyright © 2017Versantis AG